Skip to main content
VCbacked
Log inGet Started

BeauBrain Healthcare

Seoul, South Korea

We are dedicated to working towards prevention of Alzheimer's Disease through biomarker-based disease prediction

$3.0M raised
Aug 2024
Series A
Health CareHealth DiagnosticsMedical

Top Investors

Daewoong PharmaceuticalLotte VenturesAju IB InvestmentL&S Venture CapitalMint Venture Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about BeauBrain Healthcare

How much funding has BeauBrain Healthcare raised?
BeauBrain Healthcare has raised $3.0M in total funding. The most recent round was Series A. The last funding was announced in August 2024.
Who are BeauBrain Healthcare's investors?
BeauBrain Healthcare's investors include Daewoong Pharmaceutical, Lotte Ventures, Aju IB Investment, L&S Venture Capital, Mint Venture Partners.
Where is BeauBrain Healthcare headquartered?
BeauBrain Healthcare is headquartered in Seoul, South Korea.
What does BeauBrain Healthcare do?
We are dedicated to working towards prevention of Alzheimer's Disease through biomarker-based disease prediction
What stage is BeauBrain Healthcare at?
BeauBrain Healthcare is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"BeauBrain Healthcare — Funding & Investors." VCBacked, August 23, 2024, https://www.vcbacked.co/company/beaubrain-healthcare. Accessed June 17, 2026.
APA
VCBacked. (2024). BeauBrain Healthcare — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/beaubrain-healthcare
Wikipedia (cite web)
{{cite web |title=BeauBrain Healthcare — Funding & Investors |url=https://www.vcbacked.co/company/beaubrain-healthcare |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K